| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.02▲ | 4.96▲ | 5.01▲ | 5.16▲ | 5.61▼ |
| MA10 | 4.99▲ | 5.03▲ | 5.07▲ | 5.42▼ | 3.94▲ |
| MA20 | 5.09▲ | 5.13▲ | 5.15▲ | 5.75▼ | 2.25▲ |
| MA50 | 5.27▼ | 5.45▼ | 5.56▼ | 3.62▲ | 1.23▲ |
| MA100 | 5.64▼ | 5.92▼ | 5.84▼ | 2.07▲ | 1.51▲ |
| MA200 | 6.01▼ | 5.55▼ | 4.60▲ | 1.28▲ | 3.60▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.023▲ | 0.020▲ | 0.021▲ | -0.258▼ | 0.468▲ |
| RSI | 54.098▲ | 50.516▲ | 48.583▼ | 55.769▲ | 76.063▲ |
| STOCH | 51.466 | 37.001 | 41.774 | 16.073▼ | 76.094 |
| WILL %R | 0.000▲ | -4.255▲ | -18.182▲ | -70.833 | -28.042 |
| CCI | 114.910▲ | 78.928 | 67.651 | -60.106 | 58.804 |
|
Wednesday, April 24, 2024 05:00 AM
Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced that an abstract presenting preliminary ...
|
|
Wednesday, April 24, 2024 01:05 AM
The preliminary results from the phase 2 study investigating AFM24 in combination with the checkpoint inhibitor atezolizumab in patients with EGFR wild-type non-small cell lung cancer have been ...
|
|
Tuesday, April 23, 2024 09:00 AM
Albemarle Corp. engages in the development, manufacture, and marketing of chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, transportation ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 23/04/24 | 5.08 | 5.46 | 5.08 | 5.35 | 22,001 |
| 22/04/24 | 5.07 | 5.25 | 4.72 | 5.00 | 95,885 |
| 19/04/24 | 5.13 | 5.21 | 5.00 | 5.15 | 63,710 |
| 18/04/24 | 5.29 | 5.29 | 5.07 | 5.07 | 89,527 |
| 17/04/24 | 5.28 | 5.37 | 5.19 | 5.23 | 32,756 |
| 16/04/24 | 5.46 | 5.4991 | 5.17 | 5.37 | 40,155 |
| 15/04/24 | 5.76 | 5.9199 | 5.42 | 5.49 | 58,463 |
| 12/04/24 | 5.89 | 6.00 | 5.63 | 5.75 | 95,109 |
| 11/04/24 | 5.89 | 5.965 | 5.62 | 5.91 | 115,344 |
| 10/04/24 | 6.02 | 6.10 | 5.72 | 5.83 | 71,664 |
|
|
||||
|
|
||||
|
|